Physician profile
Shari L Smith
NPI 1851417794
$2,018.05
in general payments reported to CMS, 2019-2025
21 companies · $273 in 2025
The $273 reported for 2025 was more than what 82% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $303 · 2021: $172 · 2022: $443 · 2023: $173 · 2024: $400 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $846.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $597.31 | 2019-2025 | Bexsero |
| Supernus Pharmaceuticals, INC. | $374.21 | 2021-2024 | Qelbree, Qelbree |
| Merck Sharp & Dohme LLC | $190.02 | 2019-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Sobi, INC | $164.86 | 2019-2022 | |
| Corium, LLC | $153.99 | 2022-2023 | Azstarys |
| Ironshore Pharmaceuticals INC. | $78.50 | 2023-2024 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $71.37 | 2019-2023 | |
| Abbvie INC. | $54.50 | 2020-2022 | |
| Sanofi Pasteur INC. | $52.39 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $49.10 | 2025 | Jornay Pm |
| Kaleo, INC. | $47.26 | 2019-2020 | |
| Tris Pharma INC | $29.63 | 2019-2021 | |
| Pfizer INC. | $29.31 | 2019-2024 | |
| Genzyme Corporation | $23.67 | 2023 | |
| Adlon Therapeutics L.P. | $17.77 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noven Therapeutics, LLC | $16.10 | 2025 | Xelstrym |
| Biogen, INC. | $15.99 | 2019 | |
| Kyowa Kirin, INC. | $14.21 | 2024 | Crysvita |
| Genentech USA, INC. | $13.21 | 2019 | |
| Alk-Abello, INC | $13.16 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shari Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.